Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.23.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 03, 2022
Mar. 29, 2023
Jul. 28, 2016
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Related party payables       $ 1,217,110 $ 1,077,088  
Common share issued for services, shares       16,351 7,040  
Subscription aggregate amount receivable       $ 300,000 $ 0  
Common stock par value       $ 0.001 $ 0.001 $ 0.001
Common Stock, Shares Issued       8,102,173 7,718,636  
Ownership percentage       50.00%    
BioCorRx Pharmaceuticals [Member]            
Ownership percentage held by Company     75.80%      
Non-Controlling Interest [Member]            
Ownership percentage     24.20%      
Lucido Subscription Agreement [Member]            
Purchase price   $ 4.35        
Subscription aggregate amount receivable   $ 500,000        
Common stock par value   $ 0.001        
Common Stock, Shares Issued   114,943        
Board of Directors [Member]            
Common Stock, Shares Issued       4,285    
Common share issued, value       $ 28,949 $ 25,000  
Minimum [Member] | Joseph Galligan [Member]            
Ownership percentage 0.10% 15.00%   15.00%    
Maximum [Member] | Joseph Galligan [Member]            
Ownership percentage   20.00%   20.00%